Based on 784 businesses audited.
Medical Devices, Pharma & Biotech Reputation: Amgen (KANJINTI) (kanjinti.com)
KANJINTI avoids most corporate bullshit by leaning heavily on its regulatory ‘biosimilar’ status, which requires high-fidelity data. The BS detected is primarily ‘corporate polish’—generic headings and missing technical SEO identity markers (schema) rather than deceptive performance claims. It is a highly credible pharmaceutical resource with minor trust-theatre issues regarding review transparency.
Medical Devices, Pharma & Biotech Reputation: Amgen (KANJINTI) (kanjinti.com)
The site content perfectly aligns with the Pharma & Biotech category, focusing on biosimilarity, clinical trial equivalence (LILAC study), and FDA-approved indications. It adheres strictly to regulatory communication standards, including required Boxed Warnings and Important Safety Information (ISI).
“The score of 62 is driven primarily by technical omissions (Identity and Authority) and 'Trust Theatre' markers (unverified reviews/lack of outbound links). The site scored exceptionally well in Semantic Coherence, showing no drift between marketing promises and technical delivery. The Information Density score reflects a healthy balance of corporate branding and medical specifications.”